Else Nutrition Holdings Inc. reports developments tied to its plant-based nutrition business for infants, toddlers, children, and adults. The company’s updates center on whole-food, non-soy, non-dairy products, including toddler nutrition and baby cereal lines made with ingredients such as almonds, buckwheat, and tapioca.
Recurring news themes include U.S. infant-formula regulatory activity, FDA guidance on protein standards, product pipeline positioning, sales milestones, operating and financial progress, shareholder meeting results, governance matters, and capital-structure actions related to convertible funding agreements and equity issuance approvals.
Else Nutrition (OTCQX: BABYF) reported its Q1 2025 financial results, maintaining revenue at $2.1 million year-over-year while significantly improving operational efficiency. The company achieved a notable reduction in operating expenses by 48% to $2.2 million and increased gross profit margin to 25% from 8% in Q1 2024.
Key strategic initiatives include shifting powder formula manufacturing to Europe to reduce production costs and improve margins. The company is also optimizing its retail distribution model and pursuing regulatory advancement through Operation Stork Speed and the FY2026 Agriculture Appropriations Bill, which could streamline FDA approval pathways for plant-based infant nutrition alternatives.
The company ended Q1 2025 with a cash balance of $0.2 million, including restricted cash, and is exploring strategic collaborations to accelerate growth.
Else Nutrition (OTCQX: BABYF) has scheduled a business update conference call for Thursday, August 21, 2025, at 10:00 a.m. Eastern Time. The call will discuss the company's Q1 2025 financial results and corporate developments.
Investors can access the call via telephone (toll-free: 1-877-407-9219 for U.S. callers; +1-412-652-1274 for international) or webcast. A replay will be available through August 21, 2026, on the company's investor relations website, with telephone replay accessible until September 3, 2025.
Else Nutrition Holdings (OTCQX:BABYF) has received approval from the Toronto Stock Exchange for an additional extension to hold its 2025 Annual General Meeting (AGM). The company, which previously announced a delay on June 19, 2025, is now required to conduct the AGM by September 30, 2025.
Else Nutrition (OTCQX: BABYF) welcomes a significant legislative development as the U.S. House Appropriations Committee passes the FY2026 Agriculture and FDA Appropriations Bill. The legislation specifically directs the FDA to streamline approval pathways for plant-based, non-soy, and non-dairy infant formulas.
The bill includes crucial language supporting alternative infant formula access and calls for formal regulatory guidance for non-dairy, non-soy plant-based formulas. This initiative is part of Operation Stork Speed, the Administration's effort to accelerate innovation in infant formula. While the legislation still needs full House approval, it represents a significant step toward expanding the U.S. infant formula market and potentially expediting Else Nutrition's market access.
Else Nutrition (BABYF) CEO Hamutal Yitzhak published an op-ed in The Washington Times discussing Operation Stork Speed, an initiative aimed at modernizing infant formula regulations and increasing access to innovative nutrition options. The company has developed a plant-based infant formula as an alternative to dairy and soy-based products, targeting families with dietary restrictions and allergen sensitivities.
The company has completed pre-clinical studies and received IRB approval for its infant growth clinical study protocol. Else Nutrition is currently awaiting FDA authorization to begin clinical trials in the United States, which may be expedited through Operation Stork Speed. The initiative, launched by the Trump administration and HHS Secretary Robert F. Kennedy Jr., focuses on improving regulatory review and safety of infant formula while encouraging innovation.
Else Nutrition (BABYF) has expanded its U.S. retail presence by launching its Ready-to-Drink (RTD) products in 1,000 stores of a major grocery retail chain starting May 2025. The company's clean-label Kids RTD shakes, which were initially launched in 2024, offer a dairy-free and soy-free nutritional option for children. The products are minimally processed and whole-food-based, distinguishing themselves from other ultra-processed drinks in the market.
CEO Hamutal Yitzhak highlighted that this expansion reflects the growing consumer demand for plant-based options in the Kids RTD category. The company specializes in plant-based nutrition for early life and adult nutrition.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has provided a bi-weekly default status report following a Management Cease Trade Order (MCTO) granted by the British Columbia Securities Commission. The MCTO was issued due to delays in completing audit procedures for the company's 2024 annual financial statements. The order restricts trading by the CEO and CFO but does not affect other shareholders.
The company confirms no material changes since the initial MCTO announcement on April 1, 2025, and is working with auditors to complete the financial statements. Else Nutrition expects to file its Annual Filings, including MD&A and AIF, by May 27, 2025, with a final deadline of May 30, 2025.